| Adaptive mutation in influenza A virus non-structural gene is linked to host switching and induces a novel protein by alternative splicing M Selman, SK Dankar, NE Forbes, JJ Jia, EG Brown Emerging microbes & infections 1 (1), 1-10, 2012 | 215 | 2012 |
| Genomic and protein structural maps of adaptive evolution of human influenza A virus to increased virulence in the mouse J Ping, L Keleta, NE Forbes, S Dankar, W Stecho, S Tyler, Y Zhou, ... PloS one 6 (6), e21740, 2011 | 103 | 2011 |
| PB2 and hemagglutinin mutations are major determinants of host range and virulence in mouse-adapted influenza A virus J Ping, SK Dankar, NE Forbes, L Keleta, Y Zhou, S Tyler, EG Brown Journal of virology 84 (20), 10606-10618, 2010 | 94 | 2010 |
| Influenza A virus NS1 gene mutations F103L and M106I increase replication and virulence SK Dankar, S Wang, J Ping, NE Forbes, L Keleta, Y Li, EG Brown Virology journal 8, 1-13, 2011 | 89 | 2011 |
| Multifunctional adaptive NS1 mutations are selected upon human influenza virus evolution in the mouse NE Forbes, J Ping, SK Dankar, JJ Jia, M Selman, L Keleta, Y Zhou, ... PLoS One 7 (2), e31839, 2012 | 77 | 2012 |
| Influenza A/Hong Kong/156/1997 (H5N1) virus NS1 gene mutations F103L and M106I both increase IFN antagonism, virulence and cytoplasmic localization but differ in binding to RIG … SK Dankar, E Miranda, NE Forbes, M Pelchat, A Tavassoli, M Selman, ... Virology journal 10, 1-23, 2013 | 61 | 2013 |
| Microtubule disruption synergizes with oncolytic virotherapy by inhibiting interferon translation and potentiating bystander killing R Arulanandam, C Batenchuk, O Varette, C Zakaria, V Garcia, NE Forbes, ... Nature communications 6 (1), 6410, 2015 | 60 | 2015 |
| Oncolytic maraba virus MG1 as a treatment for sarcoma F Le Boeuf, M Selman, HH Son, A Bergeron, A Chen, J Tsang, ... International journal of cancer 141 (6), 1257-1264, 2017 | 50 | 2017 |
| Pharmacological modulation of anti-tumor immunity induced by oncolytic viruses NE Forbes, R Krishnan, JS Diallo Frontiers in oncology 4, 191, 2014 | 41 | 2014 |
| Generation and characterization of a new panel of broadly reactive anti-NS1 mAbs for detection of influenza A virus MN Rahim, M Selman, PJ Sauder, NE Forbes, W Stecho, W Xu, M Lebar, ... Journal of General Virology 94 (3), 593-605, 2013 | 34 | 2013 |
| Improved and simplified recombineering approach for influenza virus reverse genetics Q Liu, S Wang, G Ma, J Pu, NE Forbes, EG Brown, JH Liu Journal of molecular and genetic medicine: an international journal of …, 2009 | 33 | 2009 |
| The universal epitope of influenza A viral neuraminidase fundamentally contributes to enzyme activity and viral replication TM Doyle, B Jaentschke, G Van Domselaar, AM Hashem, A Farnsworth, ... Journal of Biological Chemistry 288 (25), 18283-18289, 2013 | 29 | 2013 |
| Identification of adaptive mutations in the influenza A virus non-structural 1 gene that increase cytoplasmic localization and differentially regulate host gene expression N Forbes, M Selman, M Pelchat, JJ Jia, A Stintzi, EG Brown PLoS One 8 (12), e84673, 2013 | 26 | 2013 |
| Exploiting tumor epigenetics to improve oncolytic virotherapy NE Forbes, H Abdelbary, M Lupien, JC Bell, JS Diallo Frontiers in genetics 4, 55401, 2013 | 26 | 2013 |
| Low-pathogenic avian influenza virus A/turkey/Ontario/6213/1966 (H5N1) is the progenitor of highly pathogenic A/turkey/Ontario/7732/1966 (H5N9) J Ping, M Selman, S Tyler, N Forbes, L Keleta, EG Brown Journal of general virology 93 (8), 1649-1657, 2012 | 24 | 2012 |
| Safety and efficacy of autologous tumour cell vaccines as a cancer therapeutic to treat solid tumours and haematological malignancies: a meta-analysis protocol for two … ST Khan, J Montroy, N Forbes, D Bastin, MA Kennedy, JS Diallo, N Kekre, ... BMJ open 10 (6), e034714, 2020 | 13 | 2020 |
| Safety and efficacy of autologous whole cell vaccines in hematologic malignancies: A systematic review and meta‐analysis DJ Bastin, ST Khan, J Montroy, MA Kennedy, N Forbes, AB Martel, ... Hematological Oncology 39 (4), 448-464, 2021 | 8 | 2021 |
| Vanadyl sulfate-enhanced oncolytic virus immunotherapy mediates the antitumor immune response by upregulating the secretion of pro-inflammatory cytokines and chemokines N Alluqmani, A Jirovec, Z Taha, O Varette, A Chen, D Serrano, G Maznyi, ... Frontiers in immunology 13, 1032356, 2022 | 2 | 2022 |
| Oncolytic rhabdoviruses NE Forbes, JC Bell Biology and Pathogenesis of Rhabdo-and Filoviruses, 231-261, 2015 | 1 | 2015 |
| Mutations in the influenza a virus ns1 gene and use thereof EG Brown, N Forbes, P Jihui US Patent App. 12/834,410, 2011 | 1 | 2011 |
Anwar M HashemKing Abdulaziz University,Verified email at kau.edu.sa
